L Shvidel, A Klepfish, A Berrebi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adrenal Gland NeoplasmsAdultAlkylating Agents/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntigens, CD20/immunologyCombined Modality TherapyDrug ResistanceHumansImmunization, PassiveImmunoglobulin G/bloodImmunosuppressive Agents/therapeutic useImmunotherapyLymphoma, B-Cell/bloodLymphoma, B-Cell/complicationsLymphoma, B-Cell/immunologyLymphoma, B-Cell/therapyLymphoma, Non-Hodgkin/bloodLymphoma, Non-Hodgkin/complicationsLymphoma, Non-Hodgkin/immunologyLymphoma, Non-Hodgkin/therapyMaleNeoplasm Proteins/bloodNeoplasms, Multiple PrimaryPheochromocytomaPurpura/etiologyPurpura, Thrombocytopenic, Idiopathic/drug therapyPurpura, Thrombocytopenic, Idiopathic/etiologyPurpura, Thrombocytopenic, Idiopathic/surgeryRemission InductionRituximabSplenectomy
Substances： See more » Alkylating AgentsAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntigens, CD20Immunoglobulin GImmunosuppressive AgentsNeoplasm ProteinsRituximab
Year: 2001 PMID： 11391724 DOI： 10.1002/ajh.1112
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047